180 Life Sciences Corp (ATNF) Live Share Price, Invest From India

180 Life Sciences Corp Stock Performance

as on August 16, 2025 at 6:59 am IST

Day's Low
Day's High
$6.29
Day's Price Range
$7.24
$7.09
11.28%
Downside
2.12%
Upside
52 Week's Low
52 Week's High
$0.66
52-Week Price Range
$17.46
$7.09
90.72%
Downside
146.26%
Upside

180 Life Sciences Corp share price movements today

Previous Close: $7.61
Open: $6.80
Volume: 11.3M
Day's Low - High: $6.29 - $7.24
52 Week Low - High: $0.66 - $17.46

180 Life Sciences Corp Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

180 Life Sciences Corp Stock Fundamentals & Key Indicators

Check 180 Life Sciences Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

180 Life Sciences Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of 180 Life Sciences Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
180 Life Sciences Corp	BUY	$-	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$43.6B	124.84%	141.09	8.45%
Beone Medicines Ltd	NA	$35.4B	NA	124.87	5.37%
Vertex Pharmaceuticals Incorporated	BUY	$113.6B	105.93%	29.16	32.94%
Regeneron Pharmaceuticals, Inc.	BUY	$82.2B	60.41%	18.72	31.41%

Analyst Recommendation on 180 Life Sciences Corp Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for 180 Life Sciences Corp. Average target price of $80

180 Life Sciences Corp Share Price Target

Get share price movements and forecasts by analysts on 180 Life Sciences Corp.

What analysts predicted

91.14%UPSIDE

Target Price

$80

Current Price

$7.09

Analyzed by

7 Analysts

Target

$80.00

180 Life Sciences Corp target price $80, a slight upside of 91.14% compared to current price of $7.09. According to 7 analysts rating.

180 Life Sciences Corp Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	0	-	-	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-4	-3	-10	-1	-1	0	0	-4	-2	-1
Net Profit Margin	0.00%	0.00%	0.00%	-739.09%	-644.31%	0.00%	0.00%	-4493.02%	0.00%	0.00%

180 Life Sciences Corp Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-
Gross Profit	0	-	0	0	0	0
Operating Income	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-
Net Income	-25	-10	-10	-38	-19	-6
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Global Institutional Holdings in 180 Life Sciences Corp

Funds	Holdings
Geode Capital Management, LLC	0.26%
XTX Topco Ltd	0.22%
BlackRock Inc	0.01%
Citigroup Inc	0%
Group One Trading, LP	0%

See all

Insights on 180 Life Sciences Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ATNF has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 7 days, ATNF stock has moved up by 153.5%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 91.6% return, outperforming this stock by 189.8%

About 180 Life Sciences Corp

180 Life Sciences Corp. is a biotechnology company, which focuses on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis. Its programs include Anti-TNF (Clinical), Synthetic Cannabinoid Analogs (SCAs), and a7nAChR (Preclinical). The Company also operates a back-end technology platform to operate an online blockchain casino.

Organisation	180 Life Sciences Corp
E-voting on shares	Click here to vote

FAQs

What is 180 Life Sciences Corp share price today?

180 Life Sciences Corp share price today is $7.09 as on August 16, 2025 at 1:29 am IST at the close of the market. 180 Life Sciences Corp share today touched a day high of $7.24 and a low of $6.29.

What is the 52 week high and 52 week low for 180 Life Sciences Corp share?

180 Life Sciences Corp share touched a 52 week high of $17.46 on August 13, 2025 and a 52 week low of $0.66 on April 9, 2025. 180 Life Sciences Corp stock price today i.e. August 16, 2025 at 1:29 am IST is closed at $7.09,which is 59.39% down from its 52 week high and 977.84% up from its 52 week low.

How to invest in 180 Life Sciences Corp Stock (ATNF) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for 180 Life Sciences Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in 180 Life Sciences Corp Shares that will get you 0.2116 shares as per 180 Life Sciences Corp share price of $7.09 per share as on August 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy 180 Life Sciences Corp Stock (ATNF) from India?

Indian investors can start investing in 180 Life Sciences Corp (ATNF) shares with as little as ₹93.116 or $1 (as of April 3, 2026 at 12:31 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹931.16 in 180 Life Sciences Corp stock (as per the Rupee-Dollar exchange rate as on April 3, 2026 at 12:31 pm IST). Based on 180 Life Sciences Corp share’s latest price of $7.09 as on August 16, 2025 at 1:29 am IST, you will get 1.4104 shares of 180 Life Sciences Corp. Learn more about fractional shares .